findmyKOL

Michiko Bruno, MD

Basic profile

University of Hawaiʻi at Mānoa

ORCIDNPI
RegionHonolulu, HI · WestSpecialtyNeurologyFocusNeurology
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2026Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Michiko Bruno is a Neurology physician affiliated with University of Hawaiʻi at Mānoa. OpenAlex indexes 49 publications with 1,417 citations (h-index 14).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
49publications

Distinct works indexed by OpenAlex, matched via ORCID.

1,417citations

Total citations across indexed works.

14h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
19companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

1380 Lusitana St
Ste 705
Honolulu, HI 96813

Telephone

808-537-9105

Registry record last updated 10 Mar 2010.

View the NPPES registry record

Industry payments

19 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Musculoskeletal

    82%
    Neuromuscular Blocker82%
    Onabotulinumtoxina100%Botox0%
    Part D + Part B29 patients
  • Nervous system

    17.3%
    Aromatic Amino Acid Decarboxylation Inhibitor7.4%
    Carbidopa-Levodopa68%Carbidopa-Levodopa Er23%Rytary8%
    Part D218 patients
    Gabapentinoids1.4%
    Gabapentin82%Pregabalin18%
    Part D50 patients

    + 19 more classes in this area

  • Cardiovascular

    0.6%
    Beta blocker0.4%
    Propranolol Hcl100%
    Part D21 patients
    alpha-Adrenergic Agonist0.3%
    Midodrine Hcl100%
    Part D11 patients
Where care is delivered (Part B)0% facility · 100% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”